SHAYLYNN SKORKA: Open Payments
NPI 1952073959 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,700 in 68 payments from 25 companies in 2025. Trend: 2023 $527 · 2024 $988 · 2025 $1,700
Food & beverage: $1,700
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $243 |
| Merck Sharp & Dohme LLC | 6 | $207 |
| GlaxoSmithKline, LLC. | 5 | $173 |
| Novartis Pharmaceuticals Corporation | 9 | $172 |
| ABBVIE INC. | 5 | $142 |
| PFIZER INC. | 1 | $118 |
| Janssen Biotech, Inc. | 5 | $103 |
| Genentech USA, Inc. | 5 | $94 |
| Ferring Pharmaceuticals Inc. | 3 | $56 |
| Exelixis Inc. | 2 | $42 |
Products named: KEYTRUDA, LYNPARZA, ELREXFIO, KISQALI, ELAHERE, JEMPERLI, ADSTILADRIN, Polivy.
Industry payments across NY — which companies pay providers there.
